Economic healthcare costs of Clostridium difficile infection: a systematic review

摘要: Clostridium difficile infection (CDI) is the leading cause of infectious diarrhoea in hospitalised patients. CDI increases patient healthcare costs due to extended hospitalisation, re-hospitalisation, laboratory tests and medications. However, economic on systems remain uncertain. The purpose this study was perform a systematic review summarise available studies aimed at defining CDI. We conducted literature search for peer-reviewed that investigated associated with (1980 present). Thirteen met inclusion exclusion criteria. 2008 US dollars were calculated using consumer price index. total incremental primary recurrent estimated. Of 13, 10 from USA one each Canada, UK, Ireland. In US-based cost estimates ranged $2,871 $4,846 per case $13,655 $18,067 special populations (subjects irritable bowel disease, surgical inpatients, patients treated intensive care unit) showed an range $6,242 $90,664. Non-US-based estimated $5,243 $8,570 Economic high cases. justifies use additional resources prevention control.